Rifabutin is a less potent inducer of CYP3A4 and has little, if any, effect on the serum concentrations of ritonavir-boosted protease-inhibitors and has been used in HIV-TB co-infected adults [72]. The gene discussed is CYP3A4; the disease is tuberculosis.